Whitnell & Co’s Zimmer Biomet ZBH Stock Holding History

Whitnell & Co’s Portfolio ZBH Stock Details ZBH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q4	$120K	Hold	828	–	–	0.04%	171
2019 Q3	$110K	Buy	+828	New	+$107K	0.04%	173

Other funds holding ZBH

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Nuveen Charlotte, North Carolina $369B AUM 31.66% 1-Year Est. Return

American Century Companies Kansas City, Missouri $194B AUM 35% 1-Year Est. Return

Boston Partners Boston, Massachusetts $95.5B AUM 28.4% 1-Year Est. Return

Whitnell & Co's ZBH Position: Q4 2019 in Review

Whitnell & Co held its Zimmer Biomet (ZBH) position steady in Q4 2019 at 828 shares worth $120K. The position accounts for 0.04% of the portfolio, ranked #171.

Whitnell & Co first reported a position in ZBH in Q3 2019 and has held it in 2 quarters since. 989 funds tracked by Wall St. Rank hold ZBH as of Q4 2019.

Whitnell & Co held 828 shares of Zimmer Biomet worth $120K as of Q4 2019.
Whitnell & Co left its Zimmer Biomet share count unchanged in Q4 2019.
Zimmer Biomet made up 0.04% of Whitnell & Co's portfolio in Q4 2019, its #171 holding.
Whitnell & Co first reported a position in Zimmer Biomet in Q3 2019 and has held it in 2 quarters since.
989 funds tracked by Wall St. Rank held Zimmer Biomet as of Q4 2019.

Based on Whitnell & Co's 13F filing for Q4 2019, filed 11 Feb 2020.